Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Pulmonary arterial hypertension.

Azad Raiesdana1, Joseph Loscalzo

  • 1Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.

Annals of Medicine
|April 4, 2006
PubMed
Summary

Pulmonary arterial hypertension (PAH) involves small artery narrowing, leading to right heart failure. Its complex causes require genetic and environmental factors, with no current cure but improving treatments available.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

De Novo Exposomic Geospatial Assembly of Chronic Disease Regions with Machine Learning & Network Analysis.

medRxiv : the preprint server for health sciences·2024
Same author

Decoding the Foodome: Molecular Networks Connecting Diet and Health.

Annual review of nutrition·2024
Same author

Disease gene prioritization with quantum walks.

Bioinformatics (Oxford, England)·2024
Same author

DREAMER: Exploring Common Mechanisms of Adverse Drug Reactions and Disease Phenotypes through Network-Based Analysis.

bioRxiv : the preprint server for biology·2024
Same author

Metabolic Responses to Redox Stress in Vascular Cells.

Antioxidants & redox signaling·2024
Same author

Broadcasters, receivers, functional groups of metabolites, and the link to heart failure by revealing metabolomic network connectivity.

Metabolomics : Official journal of the Metabolomic Society·2024

Area of Science:

  • Cardiovascular Medicine
  • Pulmonology
  • Pathophysiology

Background:

  • Pulmonary arterial hypertension (PAH) is a progressive disease of the small pulmonary arteries.
  • It is characterized by vascular narrowing, increased pulmonary vascular resistance, and eventual right ventricular failure.
  • Contributing factors include vasoconstriction, vascular proliferation, remodeling, and thrombosis.

Purpose of the Study:

  • To review the multifactorial pathogenesis of pulmonary arterial hypertension (PAH).
  • To discuss the contributing factors and disease associations of PAH.
  • To highlight current therapeutic strategies and future outlook for PAH management.

Main Methods:

  • Review of existing literature on pulmonary arterial hypertension (PAH) pathogenesis.
  • Analysis of etiological factors, including genetic, environmental, and acquired disorders.
  • Summary of current treatment options and their impact on symptoms and survival.

Main Results:

  • PAH pathogenesis is complex and multifactorial, not attributable to a single cause.
  • Susceptibility combined with a second insult likely triggers clinically apparent PAH.
  • While no cure exists, novel therapies improve symptoms and survival rates.

Conclusions:

  • Pulmonary arterial hypertension (PAH) results from a complex interplay of factors.
  • Genetic predisposition, environmental exposures, and acquired conditions contribute to PAH development.
  • Current treatments offer symptomatic relief and improved survival, though a cure remains elusive.

Related Experiment Videos